A new scientific paper published in the European Journal of Human Genetics has confirmed that the number of people worldwide living with a rare disease is estimated at 300 million. […]| Rare Diseases International
- Approximately 1,000 patients in the U.S. 12 years of age and older are now eligible for this one-time treatment- ZUG, Switzerland and BOSTON , Jan. 16, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines| CRISPR Therapeutics
Mark Zuckerberg: Priscilla and I just shared our next major focus for the Chan Zuckerberg Initiative.| Chan Zuckerberg Initiative
It's not just Medicaid or Medicare: Private insurance payments lag in rural areas.| TIME
Two new therapies—one which uses the gene-editing technology—treat sickle cell anemia.| TIME
And why it may not be a good idea to try| TIME
